|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
218,850,000 |
Market
Cap: |
39.94(B) |
Last
Volume: |
90,505,923 |
Avg
Vol: |
10,473,413 |
52
Week Range: |
$182.5 - $182.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Moriarty John B |
EVP & General Counsel |
|
2015-08-07 |
4 |
S |
$190.01 |
$25,651 |
D/D |
(135) |
42,283 |
|
- |
|
Hallal David |
CEO |
|
2015-08-07 |
4 |
S |
$190.01 |
$62,513 |
D/D |
(329) |
143,187 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2015-08-07 |
4 |
S |
$190.01 |
$30,972 |
D/D |
(163) |
27,461 |
|
- |
|
Moriarty John B |
EVP & General Counsel |
|
2015-08-05 |
4 |
OE |
$92.65 |
$1,853,000 |
D/D |
20,000 |
42,418 |
|
- |
|
Moriarty John B |
EVP & General Counsel |
|
2015-08-05 |
4 |
S |
$198.12 |
$1,986,377 |
D/D |
(10,010) |
32,418 |
|
- |
|
Bell Leonard |
Director |
|
2015-08-04 |
4 |
S |
$196.52 |
$432,344 |
D/D |
(2,200) |
920,091 |
|
- |
|
Carmichael Clare |
EVP, Chief HR Officer |
|
2015-08-04 |
4 |
S |
$196.52 |
$36,356 |
D/D |
(185) |
27,624 |
|
- |
|
Hallal David |
CEO |
|
2015-08-04 |
4 |
S |
$196.52 |
$120,270 |
D/D |
(612) |
143,516 |
|
- |
|
Sinha Vikas |
EVP & CFO |
|
2015-08-04 |
4 |
S |
$196.52 |
$132,651 |
D/D |
(675) |
166,646 |
|
- |
|
Mackay Martin |
EVP & Global Head of R&D |
|
2015-08-03 |
4 |
S |
$195.19 |
$8,548,418 |
D/D |
(43,500) |
32,893 |
|
- |
|
Mackay Martin |
EVP & Global Head of R&D |
|
2015-08-03 |
4 |
OE |
$104.86 |
$5,667,488 |
D/D |
43,500 |
76,393 |
|
- |
|
Baker Bros Advisors Llc |
Director |
|
2015-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,392 |
6,103,727 |
|
- |
|
Baker Bros Advisors Llc |
Director |
|
2015-06-22 |
4/A |
A |
$0.00 |
$0 |
I/I |
6,703,606 |
6,103,031 |
|
- |
|
Baker Bros Advisors Llc |
Director |
|
2015-06-22 |
4/A |
A |
$0.00 |
$0 |
D/D |
131,963 |
66,153 |
|
- |
|
Baker Bros Advisors Llc |
Director |
|
2015-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
6,703,611 |
6,103,033 |
|
- |
|
Baker Bros Advisors Llc |
Director |
|
2015-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
131,965 |
66,154 |
|
- |
|
Bell Leonard |
Director |
|
2015-06-18 |
4 |
AS |
$179.63 |
$5,000,001 |
D/D |
(27,835) |
922,291 |
|
- |
|
Moriarty John B |
EVP & General Counsel |
|
2015-06-11 |
4 |
S |
$170.00 |
$155,380 |
D/D |
(914) |
32,428 |
|
- |
|
Monnet Dominique |
SVP, Chief Marketing Officer |
|
2015-05-20 |
4 |
S |
$162.40 |
$41,574 |
D/D |
(256) |
8,787 |
|
- |
|
Mackay Martin |
EVP & Global Head of R&D |
|
2015-05-14 |
4 |
S |
$160.33 |
$650,298 |
D/D |
(4,056) |
32,893 |
|
- |
|
Rummelt Andreas |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
13,486 |
|
- |
|
Parven Alvin S |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
5,540 |
|
- |
|
Bell Leonard |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
950,126 |
|
- |
|
Veneman Ann M |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
4,147 |
|
- |
|
Mollen John T |
Director |
|
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
1,530 |
|
- |
|
1501 Records found
|
|
Page 18 of 61 |
|
|